Technical Analysis for CAPR - Capricor Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
A | 21.65 | 26.83% | 4.58 |
CAPR closed up 26.83 percent on Friday, October 4, 2024, on 3.53 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Range Bar | Range Expansion | 0.00% | |
New 52 Week High | Strength | 0.00% | |
Parabolic Rise | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Multiple of Ten Bullish | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% |
Alert | Time |
---|---|
5x Volume Pace | about 22 hours ago |
Up 2 ATRs | about 22 hours ago |
60 Minute Opening Range Breakout | about 22 hours ago |
3x Volume Pace | about 23 hours ago |
Up 10% | about 23 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Capricor Therapeutics, Inc., a biotechnology company, is focused on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. The company was founded in 2005 and is based in Beverly Hills, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Cardiovascular Disease Vascular Disease Regulus Therapeutics
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Cardiovascular Disease Vascular Disease Regulus Therapeutics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 21.98 |
52 Week Low | 2.68 |
Average Volume | 2,845,523 |
200-Day Moving Average | 5.35 |
50-Day Moving Average | 6.05 |
20-Day Moving Average | 8.84 |
10-Day Moving Average | 13.08 |
Average True Range | 1.83 |
RSI (14) | 94.60 |
ADX | 53.21 |
+DI | 60.52 |
-DI | 3.43 |
Chandelier Exit (Long, 3 ATRs) | 16.48 |
Chandelier Exit (Short, 3 ATRs) | 9.48 |
Upper Bollinger Bands | 19.46 |
Lower Bollinger Band | -1.77 |
Percent B (%b) | 1.1 |
BandWidth | 239.99 |
MACD Line | 3.51 |
MACD Signal Line | 2.10 |
MACD Histogram | 1.4149 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 28.36 | ||||
Resistance 3 (R3) | 27.72 | 24.85 | 27.24 | ||
Resistance 2 (R2) | 24.85 | 23.14 | 25.17 | 26.86 | |
Resistance 1 (R1) | 23.25 | 22.09 | 24.05 | 23.89 | 26.49 |
Pivot Point | 20.38 | 20.38 | 20.78 | 20.70 | 20.38 |
Support 1 (S1) | 18.78 | 18.67 | 19.58 | 19.42 | 16.81 |
Support 2 (S2) | 15.91 | 17.62 | 16.23 | 16.44 | |
Support 3 (S3) | 14.31 | 15.91 | 16.06 | ||
Support 4 (S4) | 14.95 |